Rocket Pharmaceuticals (RCKT) Stock: Buy, Sell, or Hold?
RCKT - Rocket Pharmaceuticals, Inc. Common Stock
$2.59
-0.04 (-1.52%)
▼
5d:
-3.72%
30d:
-30.56%
90d:
-32.55%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When RCKT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RCKT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RCKT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RCKT is currently trading at $2.59, which is considered oversold relative to its 30-day fair value range of $2.93 to $3.79.
Technical Outlook: Technically, RCKT is in a uptrend. Immediate support is located at $2.51, while resistance sits at $3.56.
Market Sentiment: RCKT scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.85 (+241.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RCKT is in a uptrend. Immediate support is located at $2.51, while resistance sits at $3.56.
Market Sentiment: RCKT scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.85 (+241.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.93 -
$3.79
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 241.9% below Wall St target ($8.85)
- CAUTION: Bottoming setup, but lagging the sector by 45% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$2.93 -
$3.79
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.51
Resistance Level
$3.56
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.99
Wall Street Target
$8.85
(+241.9%)
Share & Embed Analysis
Last updated: October 01, 2026 6:45 PM ET
Data refreshes hourly during market hours. Next update: 7:45 PM
Data refreshes hourly during market hours. Next update: 7:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCKT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 68 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 63 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 68 BUY |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
13 analysts |
$36 | 71 BUY |
